{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"JAK Inhibitors in Action: Effectiveness in Atopic Dermatitis","description":"This is the second episode of our new &quot;Program on JAK Inhibitors for Atopic Dermatitis&quot; series, hosted by expert dermatologist Dr. Christopher Bunick, MD, PhD. This episode, &quot;JAK Inhibitors in Action: Effectiveness in Atopic Dermatitis&quot;, featuring expert dermatologist Dr. James Song, MD, discusses the following topics:   Short- and long-term efficacy and safety data for JAK inhibitor therapies&amp;nbsp;   New topline data from the LEVEL UP trial studying upadacitinib in comparison to dupilumab for the treatment of patients aged 12 years and older with moderate-to-severe AD&amp;nbsp;   Head-to-head studies and real-world evidence evaluating JAK inhibitor therapies&amp;nbsp;   Emerging clinical developments and what's coming next in JAK inhibitor research&amp;nbsp;   ","author_name":"DermDocs","author_url":"http:\/\/dermdocs.libsyn.com\/website","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/31457067\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/172434162"}